Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 62 articles: HTML format

Single Articles

May 2022
1. ANKER SD, Butler J, Packer M
   Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply.
   N Engl J Med. 2022;386:e57.
   PubMed    
   
   
   
2. HEERSPINK HJL, Inker L, Greene T
   Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
   N Engl J Med. 2022;386:e57.
   PubMed    
   
   
   
3. AMATO J JR
   Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
   N Engl J Med. 2022;386:e57.
   PubMed    
   
   
   
4. TRIPOSKIADIS FK, Xanthopoulos A, Iliodromitis EK
   Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
   N Engl J Med. 2022;386:e57.
   PubMed    
   
   
   
5. BHATTACHARYYA D, Kar A, Dhumale S
   Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
   N Engl J Med. 2022;386:e57.
   PubMed    
   
   
   November 2021
6. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
   Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
   N Engl J Med. 2021;385:1845-1855.
   PubMed     Abstract available
   
   
   September 2021
7. KITZMAN DW, Pastva AM, Mentz RJ
   Physical Rehabilitation in Patients with Heart Failure. Reply.
   N Engl J Med. 2021;385:1340-1341.
   PubMed    
   
   
   
8. DUPONT J, Koppo K, Gielen E
   Physical Rehabilitation in Patients with Heart Failure.
   N Engl J Med. 2021;385:1340.
   PubMed    
   
   
   
9. SCHUTTLER D, Weckbach LT, Brunner S
   Physical Rehabilitation in Patients with Heart Failure.
   N Engl J Med. 2021;385:1339-1340.
   PubMed    
   
   
   
10. FRUSH BW
    Cool Water.
    N Engl J Med. 2021;385:1254-1255.
    PubMed    
    
    
    August 2021
11. ANKER SD, Butler J, Filippatos G, Ferreira JP, et al
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMoa2107038.
    PubMed     Abstract available
    
    
    
12. DRAZNER MH
    SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable Foe.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMe2113008.
    PubMed    
    
    
    
13. PACKER M, Butler J, Zannad F, Pocock SJ, et al
    Empagliflozin and Major Renal Outcomes in Heart Failure.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMc2112411.
    PubMed    
    
    
    
14. JOYNT MADDOX KE, Orav EJ, Zheng J, Epstein AM, et al
    Year 1 of the Bundled Payments for Care Improvement-Advanced Model.
    N Engl J Med. 2021;385:618-627.
    PubMed     Abstract available
    
    
    May 2021
15. TEERLINK JR, Felker GM, McMurray JJV
    Omecamtiv Mecarbil in Systolic Heart Failure. Reply.
    N Engl J Med. 2021;384:1967-1968.
    PubMed    
    
    
    
16. BELLUMKONDA L
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    PubMed    
    
    
    
17. BONAPACE S, Molon G
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    PubMed    
    
    
    
18. KOMAMURA K
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1966-1967.
    PubMed    
    
    
    
19. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    PubMed    
    
    
    
20. ANKER SD, Coats AJS
    Exercise for Frail, Elderly Patients with Acute Heart Failure - A Strong Step Forward.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMe2106140.
    PubMed    
    
    
    
21. KITZMAN DW, Whellan DJ, Duncan P, Pastva AM, et al
    Physical Rehabilitation for Older Patients Hospitalized for Heart Failure.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2026141.
    PubMed     Abstract available
    
    
    April 2021
22. LEE TH
    Zoom Family Meeting.
    N Engl J Med. 2021;384:1586-1587.
    PubMed    
    
    
    January 2021
23. PACKER M, Zannad F
    Empagliflozin in Heart Failure. Reply.
    N Engl J Med. 2021;384:387-388.
    PubMed    
    
    
    
24. KUMAR S, Sinha S
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:387.
    PubMed    
    
    
    
25. GERARD AO, Favre G, Esnault VLM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386-387.
    PubMed    
    
    
    
26. SHANMUGANATHAN M, Goswami RM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386.
    PubMed    
    
    
    
27. BHATTACHARYYA D, Kar A
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385-386.
    PubMed    
    
    
    
28. FAUCHIER L, Fauchier G, Angoulvant D
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385.
    PubMed    
    
    
    
29. LIN X, Wang S, Huang J
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:384-385.
    PubMed    
    
    
    
30. SWEDBERG K
    Stimulation of Contractility in Systolic Heart Failure.
    N Engl J Med. 2021;384:178-179.
    PubMed    
    
    
    
31. RUDDER M, Russo M, Ventetuolo CE
    Breathing for Two.
    N Engl J Med. 2021;384:61-68.
    PubMed    
    
    
    November 2020
32. BHATT DL, Szarek M, Steg PG, Cannon CP, et al
    Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
    N Engl J Med. 2020 Nov 16. doi: 10.1056/NEJMoa2030183.
    PubMed     Abstract available
    
    
    
33. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
    Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2025797.
    PubMed     Abstract available
    
    
    October 2020
34. ARMSTRONG PW, Anstrom KJ, O'Connor CM
    Vericiguat in Heart Failure with Reduced Ejection Fraction. Reply.
    N Engl J Med. 2020;383:1497-1498.
    PubMed    
    
    
    
35. RYAN JJ, Maron BA
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1497.
    PubMed    
    
    
    
36. WEARDEN J, Hough A, Kaiser S
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1496-1497.
    PubMed    
    
    
    August 2020
37. JARCHO JA
    More Evidence for SGLT2 Inhibitors in Heart Failure.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMe2027915.
    PubMed    
    
    
    
38. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2022190.
    PubMed     Abstract available
    
    
    
39. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    PubMed     Abstract available
    
    
    June 2020
40. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;382:2238-2247.
    PubMed    
    
    
    May 2020
41. BURNETT JC JR
    Vericiguat - Another Victory for Targeting Cyclic GMP in Heart Failure.
    N Engl J Med. 2020;382:1952-1953.
    PubMed    
    
    
    April 2020
42. EPSTEIN JA, Rosenthal N, Feldman AM
    Teasing the Immune System to Repair the Heart.
    N Engl J Med. 2020;382:1660-1662.
    PubMed    
    
    
    March 2020
43. ARMSTRONG PW, Pieske B, Anstrom KJ, Ezekowitz J, et al
    Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020 Mar 28. doi: 10.1056/NEJMoa1915928.
    PubMed     Abstract available
    
    
    
44. SOLOMON SD, McMurray JJV
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply.
    N Engl J Med. 2020;382:1182-1183.
    PubMed    
    
    
    
45. LEWIS GA, Schelbert EB, Miller CA
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1182.
    PubMed    
    
    
    
46. YAZDANI B, Lutz N, Kramer BK
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1181-1182.
    PubMed    
    
    
    
47. BAPTISTA R, Moraes-Sarmento P, Fontes-Carvalho R
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1181.
    PubMed    
    
    
    
48. GUPTA K, Bajaj NS
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1180-1181.
    PubMed    
    
    
    
49. VAN DE BOVENKAMP AA, van Rossum AC, Handoko ML
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1180.
    PubMed    
    
    
    
50. MCMURRAY JJV, Docherty KF, Jhund PS
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. Reply.
    N Engl J Med. 2020;382:973.
    PubMed    
    
    
    
51. VIEIRA JL, Mehra MR
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020;382:972-973.
    PubMed    
    
    
    
52. PELED H, Dau NQ
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020;382:972.
    PubMed    
    
    
    
53. BORGHI C, Cicero AFG
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020;382:972.
    PubMed    
    
    
    February 2020
54. PAULUS WJ
    Unfolding Discoveries in Heart Failure.
    N Engl J Med. 2020;382:679-682.
    PubMed    
    
    
    
55. D'SILVA K, Cockrill B, Anderson WJ, Miller AL, et al
    A Rapid Change in Pressure.
    N Engl J Med. 2020;382:563-570.
    PubMed    
    
    
    January 2020
56. AZAR MM, Muse VV, Villalba JA, Turbett SE, et al
    Case 2-2020: A 64-Year-Old Man with Fever and Respiratory Failure.
    N Engl J Med. 2020;382:276-285.
    PubMed    
    
    
    December 2019
57. PACKER M
    Why Are Physicians So Confused about Acute Heart Failure?. Reply.
    N Engl J Med. 2019;381:2375-2376.
    PubMed    
    
    
    
58. FINUCANE TE
    Why Are Physicians So Confused about Acute Heart Failure?
    N Engl J Med. 2019;381:2375.
    PubMed    
    
    
    
59. ELLISON DH
    Why Are Physicians So Confused about Acute Heart Failure?
    N Engl J Med. 2019;381:2374-2375.
    PubMed    
    
    
    November 2019
60. KITTLESON MM
    A Good Physician - On Complacency and Communication.
    N Engl J Med. 2019;381:1798-1799.
    PubMed    
    
    
    October 2019
61. O'CONNOR CM, deFilippi C
    PARAGON-HF - Why We Do Randomized, Controlled Clinical Trials.
    N Engl J Med. 2019;381:1675-1676.
    PubMed    
    
    
    
62. BERNSTEIN SN, Cudemus-Deseda GA, Ortiz VE, Goodman A, et al
    Case 33-2019: A 35-Year-Old Woman with Cardiopulmonary Arrest during Cesarean Section.
    N Engl J Med. 2019;381:1664-1673.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: